1-9 of 9
Kerstin Maria Kampa-Schittenhelm
Close
Sort by
Journal Articles

A New Class of Synthetic Type-B Polycyclic Polyprenylated Acylphloroglucinols (PPAP-B) Overcomes Venetoclax-Resistance in Acute Myeloid Leukemia (AML)

Leonie Elisabeth Kampa, Anton Bleisch, Philipp Peslalz, Marcus Matthias Schittenhelm, Bernd Plietker, Kerstin Maria Kampa-Schittenhelm
Journal: Blood
Blood (2023) 142 (Supplement 1): 4157.
https://doi.org/10.1182/blood-2023-189692
Published: 2023
Journal Articles

Overexpression of Oncogenic Inhibitory-ASPP (inhibitor of apoptosis stimulating protein of p53) Results in Therapy Resistance and Adverse Outcome in AML

Marcus Matthias Schittenhelm, Mihada Bajrami Saipi, Gunnar Blumenstock, Peter JM Valk, Balazs Györffy, Kerstin Maria Kampa-Schittenhelm
Journal: Blood
Blood (2022) 140 (Supplement 1): 3433–3434.
https://doi.org/10.1182/blood-2022-170405
Published: 2022
Journal Articles

ASPP2 k , a Dominant-Negative Splicing Variant of the Apoptosis-Stimulating Protein of p53-2 (ASPP2), Modulates Treatment Response Towards BCL-Signaling Inhibitors in Acute Myeloid Leukemia

Marcus M. Schittenhelm, Vasileia Tsintari, Rebecca Fröhlich, Kerstin Maria Kampa-Schittenhelm
Journal: Blood
Blood (2021) 138 (Supplement 1): 3343.
https://doi.org/10.1182/blood-2021-152312
Published: 2021
Journal Articles

Attenuation of the Apoptosis Stimulating Protein of TP53-1 (ASPP1) Is a Predictive Marker for Therapy Resistance and Overall Survival in Acute Myeloid Leukemia (AML)

Marcus M. Schittenhelm, Max Kaiser, Vasileia Tsintari, Gunnar Blumenstock, Balazs Györffy, Kerstin Maria Kampa-Schittenhelm
Journal: Blood
Blood (2021) 138 (Supplement 1): 1298.
https://doi.org/10.1182/blood-2021-152531
Published: 2021
Journal Articles

Dysregulation of the ASPP Protein Family (Apoptosis Stimulating Proteins of TP53) Is a Common Feature in High-Risk Acute Myeloid Leukemia (AML)

Kerstin Maria Kampa-Schittenhelm, MD, Max Kaiser, Mihada Bajrami Saipi, Bianca Walter, Gunnar Blumenstock, Lothar Kanz, Marcus M Schittenhelm, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1231.
https://doi.org/10.1182/blood.V130.Suppl_1.1231.1231
Published: 2017
Journal Articles

Oncogenic Splicing of the Apoptosis-Stimulating Protein of p53-2 ( ASPP2 ) Is an Initiating Step in Leukemogenesis Facilitating Acquisition of Structural Genomic Mutations

Kerstin Maria Kampa-Schittenhelm, MD, Ulrike Mau-Holzmann, Charles Lopez, MD PhD, Marcus M. Schittenhelm
Journal: Blood
Blood (2016) 128 (22): 1555.
https://doi.org/10.1182/blood.V128.22.1555.1555
Published: 2016
Journal Articles

Attenuation of Apoptosis Stimulating Protein of p53-1 (ASPP1) Associates with Therapy Failure in Acute Myeloid Leukemia (AML)

Marcus M. Schittenhelm, Max Kaiser, Gunnar Blumenstock, Kerstin Maria Kampa-Schittenhelm, MD
Journal: Blood
Blood (2016) 128 (22): 1556.
https://doi.org/10.1182/blood.V128.22.1556.1556
Published: 2016
Journal Articles

Epigenetic Upregulation of the O-Linked Beta-N-Acetylglucosamine Transferase (OGT) in Response to Dronabinol Results in Antileukemic Efficacy In Vivo

Kerstin Maria Kampa-Schittenhelm, MD, Hans-Joerg Buehring, Michael Bonin, Wichard Vogel, MD, Lothar Kanz, Prof. Dr. MD, Thomas Haverkamp, Marcus M Schittenhelm, MD
Journal: Blood
Blood (2015) 126 (23): 2437.
https://doi.org/10.1182/blood.V126.23.2437.2437
Published: 2015
Journal Articles

Attenuation of Apoptosis-Stimulating Protein of p53-2 (ASPP2) Promotes IL-3-Independent Growth and Enhances Cytogenetic Abnormalities after Gamma-Irradiation in Mouse Hematopoietic Cells - Mimicking Early Leukemogenesis of Therapy-Associated Human AML

Kerstin Maria Kampa-Schittenhelm, MD, Ulrike Mau-Holzmann, Lothar Kanz, Prof. Dr. MD, Charles Lopez, MD PhD, Marcus M Schittenhelm, MD
Journal: Blood
Blood (2015) 126 (23): 2460.
https://doi.org/10.1182/blood.V126.23.2460.2460
Published: 2015